SE1 - Oppotunities from NanoDX itself ( Huge Potential Revenue)

Congratuations to great work from @VatreniHR @Jimmymejules @dpdebrec , now it is so encourging to see NanoDx covid detection system used Sensera sensor, and not only this product, also Traumatic Brain Injury (TBI), Sepsis and Stroke. This sensor technology will bring endless oppotunies for Sensera now, lets just look at NanoDX website at https://nanodiagnostics.com/

• NanoDX Company VISION

OURVISION is to be the world’s leader in nanosensor-based,point-of-care diagnostics for a wide variety of diseases including Covid-19, TraumaticBrain Injury (TBI), Sepsis and Stroke.

• Huge oppotunites from Covid-19, Traumatic Brain Injury (TBI), Sepsis and Stroke

NanoDxTM is conducting diagnostics research on a wide range of applications including traumatic brain injury, sepsis and stroke. Combined with COVID-19, these diseases affect more than 634 million people around the world each year.

Just take note that one cartridge is only can be tested for once, which means that multiple test will need much more than 634m sensors, I just guess that Sensera can receive USD 5 per cartridge sensor, and the revenue generated from this can be more than USD 3bil;


In the updated pipeline released during AGM, Ralph only very conservatively to put US$10mil from covid 19 sensor, it seems to me this figure is very easy to achieve this financial year, but we must understand that this technology is not only limited to Covid 19, it will be widely used to other deseases and the oppotunities are very huge from here.


All are just personal understanding from available information, please do your own research to make decision. GLTA!!